Parametric Portfolio Associates’s OptimizeRx OPRX Stock Holding History

Parametric Portfolio Associates’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$887K	Sell	23,515 -11,570	-33%	-$512K	﹤0.01%	2834
2021 Q4	$2.18M	Sell	35,085 -44,105	-56%	-$3.34M	﹤0.01%	2390
2021 Q3	$6.78M	Buy	79,190 +35,343	+81%	+$2.22M	﹤0.01%	1629
2021 Q2	$2.71M	Buy	43,847 +6,264	+17%	+$319K	﹤0.01%	2262
2021 Q1	$1.83M	Buy	+37,583	New	+$1.81M	﹤0.01%	2837
2019 Q4	–	Sell	-18,076	Closed	-$262K	–	3990
2019 Q3	$262K	Buy	+18,076	New	+$280K	﹤0.01%	3605

Other funds holding OPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Parametric Portfolio Associates's OPRX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its OptimizeRx (OPRX) stake by 33% in Q1 2022, selling an estimated $512K and leaving 23,515 shares worth $887K. The position accounts for ﹤0.01% of the portfolio, ranked #2834.

Parametric Portfolio Associates first reported a position in OPRX in Q3 2019 and has held it in 6 quarters since. The position peaked at $6.78M in Q3 2021. 153 funds tracked by Wall St. Rank hold OPRX as of Q1 2022.

Parametric Portfolio Associates held 23,515 shares of OptimizeRx worth $887K as of Q1 2022.
Parametric Portfolio Associates sold 11,570 OptimizeRx shares in Q1 2022, an estimated $512K.
OptimizeRx made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2834 holding.
Parametric Portfolio Associates first reported a position in OptimizeRx in Q3 2019 and has held it in 6 quarters since.
Parametric Portfolio Associates's OptimizeRx position peaked at $6.78M in Q3 2021.
153 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.